What’s In A Name? Hatch And Waxman Stake Claims To Generic Biologics Bill

Sen. Orrin Hatch, R-Utah, and Rep. Henry Waxman, D-Calif., continue to disagree on how to move toward what could be the next major milestone in the generics industry they essentially created in 1984: generic biologics

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet